Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0145014 PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES
The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula...
2017/0145013 DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF
The present disclosure provides compounds of Formula (I), and pharmaceutically compositions thereof. Compounds of Formula (I) have been found to bind...
2017/0145012 PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS
The application relates to inhibitors of USP1 useful in the treatment of cancers, and other USP1 associated diseases and disorders, having the Formula: ...
2017/0145011 Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channels
The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides...
2017/0145010 SUBSTITUTED PYRAZINO[2,2-a]ISOQUINOLINE DERIVATIVES
The present invention relates to compounds of formula of formula I wherein R, R.sup.2and L are as described herein, compositions containing compounds of...
2017/0145009 HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEFUL FOR TREATING VARIOUS CANCERS
The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula IA or Formula IB, as well...
2017/0145008 VALBENAZINE SALTS AND POLYMORPHS THEREOF
Provided herein are salts of (S)-2-amino-3-methyl-butyric acid (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[- 2,1-a]isoquinolin-2-yl...
2017/0145007 PYRIMIDINE-2,4-DIAMINE DERIVATIVE AND ANTICANCER PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT
The present invention relates to a pyrimidine-2,4-diamine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for...
2017/0145006 PROCESS FOR MAKING DUOCARMYCIN PRODRUGS
The present invention relates to a process comprising converting a compound of formula (I) into a compound of formula (II) by reaction with an organolithium...
2017/0145005 KINASE INHIBITOR
[Problem] To provide a novel PIM-3 inhibitor and a novel cancer therapeutic drug, in particular, a therapeutic drug for pancreatic cancer. [Solution] A PIM-3...
2017/0145004 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)- 2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS
The invention relates to novel 3,5-dichloro,4-(3,4-(cyclo-) alkoxyphenyl)-2-carbonyloxy)ethyl)pyridine compounds which are both inhibitors of the...
2017/0145003 HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
The invention relates to compounds useful in treating conditions associated with voltage-gated ion channel function, particularly conditions associated with...
2017/0145002 DEUTERATED ISOXAZOLE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS
The present application relates to a compound of Formula (I), and to uses thereof, such as for the treatment of a neurological or psychoartic disorder. ...
2017/0145001 PROCESSES FOR PREPARING BREXPIPRAZOLE
The present disclosure provides processes for preparing brexpiprazole. The present disclosure also provides processes for the purification of brexpiprazole....
2017/0145000 CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF
The present invention relates to canagliflozin Monohydrate and its crystalline forms. Compared to the prior art, canagliflozin Monohydrate and its crystalline...
2017/0144999 THERAPEUTIC SUBSTITUTED CYCLOPENTANES
Disclosed herein are compounds having formula (I) wherein a dashed line represents the presence or absence of a bond; Y is an organic acid functional group, or...
2017/0144998 ELASTASE INHIBITORS
Described herein are compounds, compositions, and methods of their use for the treatment of a lung or intestinal disease.
2017/0144997 MODULATORS OF CHEMOKINE RECEPTORS
Compounds are provided as chemokine inhibitors having the structure: ##STR00001##
2017/0144996 INHIBITORS OF CXCR2
Compounds are provided as inhibitors of CXCR2, having the structure: ##STR00001##
2017/0144995 AMIDE COMPOUND
A method is provided for producing an amide compound having an excellent control effect on arthropod pests. The method includes an arthropod pest control agent...
2017/0144994 SUBSTITUTED AZETIDINE DERIVATIVES
The present invention relates to compounds of formula of formula I wherein R, R.sup.1. R.sup.2, R.sup.2', R.sup.3, R.sup.4, R.sup.5, L.sup.1, L.sup.2 and N are...
2017/0144993 CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CANNABINOID RECEPTOR MODULATORS
The present invention relates to crystalline forms of (1aS,5aS)-2-(4-oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclop- ropa[a]pentalene-4-carboxylic...
2017/0144992 NOVEL FLUOROQUINOLONES AND USE THEREOF TO TREAT BACTERIAL INFECTIONS
The present invention relates to novel fluoroquinolones, pharmaceutical compositions or medicament containing them and use thereof to treat bacterial infection.
2017/0144991 ANTIFUNGAL COMPOUND PROCESS
The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new...
2017/0144990 ANTIFUNGAL COMPOUND PROCESS
The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new...
2017/0144989 NOVEL CRYSTALLINE FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
The invention relates to novel crystalline forms of 3-(4-amino-l-oxo-l,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione, including a novel urea cocrystal of...
2017/0144988 ARYL-TRIAZOLYL PYRIDINES AS PEST CONTROL AGENTS
The invention relates to novel aryltriazolylpyridines of the general formula (I). Also described are processes for preparing the compounds of the formula (I)....
2017/0144987 NOVEL CRYSTALLINE POLYMORPHS OF PYRIDINE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
Disclosed are crystals of 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-c- arboxylic acid useful as therapeutic or prophylactic agents...
2017/0144986 INHIBITOR OF BRUTON'S TYROSINE KINASE
Provided are a compound represented by formula (III) or pharmaceutically acceptable salts, solvates, active metabolites, polymorphs, esters, tautomers or...
2017/0144985 DIAMINOTRIAZINE COMPOUND USEFUL AS HERBICIDE
The present invention relates to diaminotriazine compounds of the formula (I) and to their use as herbicides. The present invention also relates to ...
2017/0144984 MODULATORS OF THE RELAXIN RECEPTOR 1
Disclosed are modulators of the human relaxin receptor 1, for example, of formula (I), wherein A, R.sup.1, and R.sup.2 are as defined herein, that are useful...
2017/0144983 3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors
Provided herein are 3-phenyl-7-hydroxy-isocoumarin compounds which are MIF inhibitors; compositions comprising said inhibitors and methods for treating or...
2017/0144982 Formation of 2,5-Furan Dicarboxylic Acid from Aldaric Acids
The disclosure relates to a method for forming 2,5-furan dicarboxylic acid (FDCA) from aldaric acids. The aldaric acids are dehydrating and cyclizing via acid...
2017/0144981 METHODS AND COMPOSITIONS FOR WOUND HEALING
The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are...
2017/0144979 TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE BENEFITS
The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline,...
2017/0144978 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS
Provided is a method for treating or preventing a viral infection in a subject, wherein the viral infection is from a flavivirus selected from the group...
2017/0144977 DEUTERATED MOMELOTINIB
The present invention in one embodiment provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula...
2017/0144976 METHYLACRYLOYL BENZIMIDAZOLONE DERIVATIVE AND ANTI-TUMOUR USE THEREOF
Disclosed are a use of a methylacryloyl benzimidazolone derivative, an optical isomer or a pharmaceutically acceptable salt or prodrug thereof in the...
2017/0144975 TRIPHENYLETHYLENE COMPOUNDS AND USES THEREOF
Triphenylethylene compounds as dual aromatase inhibitors and selective estrogen receptors modulators are described. Also described are methods for treating...
2017/0144974 ACRIDONE COMPOUNDS
A class of acridone compounds has been discovered that exhibits chemosensitizing and antiparasitic activity. Described herein are pharmaceutical compositions...
2017/0144973 HETEROCYCLIC COMPOUNDS AND THEIR USE AS RETINOID-RELATED ORPHAN RECEPTOR (ROR) GAMMA-T INHIBITORS
Provided are heterocyclic compounds having a ROR.gamma.t inhibitory action represented by the formula (I): wherein each symbol is as defined in the...
2017/0144972 METHODS OF LOWERING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)
The invention relates to new methods of modulating cholesterol by inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9) with fatty acid derivatives;...
2017/0144971 Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
The present invention provides MDM2 inhibitor compounds of Formula I, ##STR00001## wherein the variables are defined above, which compounds are useful as...
2017/0144970 ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
Isoindoline sigma-2 receptor antagonist compounds, pharmaceutical compositions comprising such compounds, and methods for inhibiting Abeta-associated synapse...
2017/0144969 ANTIMICROBIAL CONJUGATES, METHOD FOR PRODUCTION AND USES THEREOF
The present disclosure relates to polyamine conjugates, its isomers, prodrugs and pharmaceutically acceptable salts thereof. The present disclosure also...
2017/0144968 PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES
The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically...
2017/0144967 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY
What is described is a compound ##STR00001## wherein R.sub.1 and R.sub.2 are the same or different, each a linear or branched alkyl with 1-9 carbons, or an...
2017/0144966 METHOD FOR PREPARING DIMETHYL DISULPHIDE
The present invention relates to a method for preparing dimethyl disulphide, in batches or continuously, preferably continuously, said method including at...
2017/0144965 MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT
A pharmaceutical composition can include: a marmelin analog compound, and a pharmaceutically acceptable carrier having the compound. The compound can be...
2017/0144964 CHARACTERIZATION OF THE COCRYSTAL PRODUCTS FORMED BY METOPROLOL AND DABIGATRAN BASES WITH L-THEANINE
Methods of making cocrystal compositions of metoprolol and dabigatran bases with enantiomers of theanine.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.